U.K. Venture Group Abingworth Attracts $375M For New Bioventures Fund
This article was originally published in The Pink Sheet Daily
Executive Summary
The BioVentures VI fund will invest across the life sciences sector in Europe and the U.S. and could herald an uptick in VC fundraising activity.